Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis

Journal of Clinical Investigation

Volumn 103, Issue 4, 1999, Pages 483-490

  Pasula, Rajamouli ^a   Wright, Jo Rae ^b   Kachel, Diane L ^a   Martin II, William J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN DERIVATIVE; OLIGOSACCHARIDE; SURFACTANT PROTEIN A;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; CYTOTOXICITY; DEGLYCOSYLATION; LUNG ALVEOLUS MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0033557301     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2991     Document Type: Article

References (71)

1. Read, C. 1996. Mycobacterium tuberculosis: a stowaway in the cell. Lancet. 348:50.
2. Raviglione, M.C., Snider, D.E., Jr., and Kocki, A. 1995. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 273:220-226.
3. Bloom, B.R., and Murray, C.J.L. 1992. Tuberculosis: commentary on a reemergent killer. Science. 257:1055-1063.
4. Rook, G., and Hernandez-Pando, R. 1996. The pathogenesis of tuberculosis. Annu. Rev. Microbiol. 50:259-284.
5. Mehta, P., King, C., White, E., Murtagh J. Jr., and Quinn, F. 1996. Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication. Infect. Immun. 64:2673-2679.
6. Bermudez, L.E., and Goodman, J. 1996. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 64:1400-1406.
7. Fenton, M.J., and Vermeulen, M.W. 1996. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect. Immun. 64:683-690.
8. Schlesinger, L.S. 1996. Role of mononuclear phagocytes in M. tuberculosis pathogenesis. J. Invest. Med. 44:312-323.
9. Chan, J., and Kaufmann, S.H. 1994. Immune mechanisms of protection. In Tuberculosis: pathogenesis, protection and control. B. Bloom, editor. ASM Press. Washington, DC. 389-415.
10. Clemens, D.L., and Horwitz, M.A. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp Med. 181:257-270.
11. Via, L.A.E., et al. 1997. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J. Biol. Chem. 272:13326-13331.
12. Schlesinger, L.S., Bellinger-Kawahara, C.G., Payne, N.R., and Horwitz, M.A.A. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C31. J. Immunol. 144:2771-2780.
13. Schlesinger, L.S., and Horwitz, M.A. 1991. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-γ activation inhibits complement receptor function and phagocytosis of this bacterium. J. Immunol. 147:1983-1994.
14. Schlesinger, L.S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150:2920-2930.
15. Roecklein, J.A., Swartz, R.P., and Yeager, H., Jr. 1992. Nonopsonic uptake of Mycobacterium avium complex by human monocytes and alveolar macrophages. J. Lab. Clin. Med. 119:772-781.
16. Peterson, P.K., et al. 1995 CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun. 63:1598-1602.
17. Ezekowitz, A.B., Sastry, K., Bailly, P., and Warner, A. 1990. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J. Exp. Med. 172:1785-1794.
18. Schorey, J.S., Carrol, M.C., and Brown, E.J. 1997. A macrophage invasion mechanism of pathogenic mycobacteria. Science. 277:1091-1093.
19. Hirsch, C.S., Ellner, J.J., Russell, D.G., and Rich, E.A. 1994. Complement receptor-mediated uptake and tumor necrosis factor-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol. 152:743-753.
20. Fels, A.O., and Cohn, ZA. 1986. The alveolar macrophage. J. Appl. Physiol. 60:353-369.
21. Ding, A.H., Nathan, C.F., and Stuehr, D.J. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2413.
22. Denis, M. 1991. Interferon-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates cell. Cell. Immunol. 132:150-157.
23. Chan, J., Xing, Y., Magliozzo, R.S., and Bloom, B.R. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
24. Flesch, I.E., and Kaufmann, S. 1991. Mechanisms involved in mycobacterial growth inhibition by interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213-3218.
25. Flynn, J.L., et al. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
26. Greenburg, S., Xie, J., Kolls, J., Mason, C., and Didier, P. 1995. Rapid induction of mRNA for nitric oxide synthase II in rat alveolar macrophages by intratracheal administration of Mycobacterium tuberculosis and Mycobacterium avium. Proc. Soc. Exp. Biol. Med. 209:46-53.
27. MacMaking, J., et al. 1997. Identification of a nitric oxide synthase as a protective locus against tuberculosis. J. Immunol. 94:5243-5248.
28. McCormack, F. 1997. The structure and function of surfactant protein-A. Chest. 111:114s-119s.
29. Hawgood, S. 1989. Pulmonary surfactant apoproteins: a review of protein and genomic structure. Am. J. Physiol. 257:L13-L21.
30. Hawgood, S., and Shiffer, K. 1991. Structures and properties of the surfactant-associated proteins. Annu. Rev. Physiol. 53:375-394.
31. Voss, T., Eistetter, H., Schafer, K., and Engel, J. 1988. Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. J. Mol. Biol. 201:219-227.
32. Tenner, A., Robinson, S., Borchelt, J., and Wright, J.R. 1989. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. J. Biol. Chem. 264:13923-13928.
33. van Iwaarden, J.F., et al. 1991. Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am. J. Physiol. 261:L204-L209.
34. McNeely, T.B., and Coonrod, J.D. 1994. Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactent protein A. Am. J. Respir. Cell Mol. Biol. 11:114-122.
35. Bobak, D.A., Gaither, T.A., Frank, M.M., and Tenner, A.J. 1987. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138:1150-1156.
36. Katsura, M., Kawada, H., and Konno, K. 1993. Rat surfactant apoprotein A (SP-A) exhibits antioxidant effects on alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 9:520-525.
37. Weber, H., Heilmann, P., Meyer, B., and Maier, K.L. 1990. Effect of canine surfactant protein (SP-A) on the respiratory burst of phagocytic cells. FEBS Lett. 270:90-94.
38. Borron, P., et al. 1996. Surfactant protein-A inhibits human lymphocyte proliferation and IL-2 production. Am. J. Respir. Cell Mol. Biol. 15:115-121.
39. van Iwaarden, J.F., Teding Van Berkout, F., Whitsett, J.A., Oosting, R.S., and van Golde, L.M. 1995. A novel procedure for the rapid isolation of surfactant protein A with retention of its alveolar-macrophage-stimulating properties. Biochem. J. 309:551-555.
40. van Iwaarden, F., Welmers, B., Verhoef, J., Haagsman, H.P., and van Golde, L.M. 1990. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 2:91-93.
41. Barnes, P.F., Bloch, A.B., Davidson, P.T., and Snider, D.E., Jr. 1991. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 324:1644-1650.
42. Downing, J.F., Pasula, R., Wright, J.R., Twigg, H.L., III, and Martin, W.J., II. 1995. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with HIV. Proc Natl. Acad. Sci. USA. 92:4848-4852.
43. Dhople, A., Dhople, A., and Ibanzez, M. 1995. In vitro activities of 2,2′-bipyridyl analogues against Mycobacterium avium and Mycobacterium tuberculosis. Tuber. Lung Dis. 76:136-140.
44. y = 26,000-36,000 enhances uptake of liposomes by type II cells. J. Biol. Chem. 262:2888-2894.
45. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
46. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
47. Gaynor, C., McCormack, F.X., Voelker, D.R., McGowan, S.E., and Schlesinger, L.S. 1995. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155:5343-5351.
48. Kuroki, Y., Mason, R.J., and Voelker, D.R. 1988. Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A. Proc. Natl. Acad Sci. USA. 85:5566-5570.
49. McIntosh, J., Swyers, A., Fisher, J., and Wright, J. 1996. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide. Am. J. Respir Cell Mol. Biol. 15:509-519.
50. Kohler, G., and Milstein, C. 1975. Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature. 256:495-497.
51. de Blas, A.L., Ratnaparkhi, M.V., and Mosimann, J.E. 1983. Estimation of the number of monoclonal hybridomas in a cell-fusion experiment. Methods Enzymol. 92:36-39.
52. Pasula, R., et al. 1997. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 17:209-217.
53. 15N] nitrite in biological fluids. Anal. Biochem. 126:131-138.
54. Raetz, C., et al. 1991. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transducrion. FASEB J. 5:2652-2660.
55. Reddy, M.V., Srinivasan, S., Andersen, B., and Gangadharam, P.R.J. 1994. Rapid assessment of mycobacterial growth inside macrophages and mice, using the radiometric (BACTEC) method. Tuber. Lung Dis. 75:127-131.
56. Kirihara, J.M., Hillier, S.L., and Coyle, M.B. 1985. Improved detection times for Mycobacterium avium and Mycobacterium tuberculosis with the BACTEC radiometric system. J. Clin. Microbiol. 22:841-845.
57. Kuebler, R.R., and H. Smith. 1976. Statistics. John Wiley and Sons. New York, NY. 175-274.
58. Cooper, A.M., et al. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
59. Orme, I.M., Roberts, A.D., Griffen, J.P., and Abrams, J.S. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151:518-525.
60. Flynn, J.L., et al. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515-2524.
61. Gong, J.H., et al. 1996. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect. Immun. 64:913-919.
62. Silverstein, S.C., Greenberg, S., Di Virgilio, F., and Steinberg, T.H. 1989. Phagocytosis. In Fundamental immunology. W.E. Paul, editor. Raven Press. New York, NY. 703-720.
63. Pison, U., Max, M., Neuendank, A., Weissbach, S., and Pietschmann, S. 1994. Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system. Eur. J. Clin. Invest. 24:586-599.
64. Wright, J.R., and Youmans, D.C. 1993. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am. J. Physiol. 264:L338-L344.
65. LeVine, A.M., et al. 1997. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J. Immunol. 158:4336-4340.
66. Blau, H., Riklis, S., Van Iwaarden, J.F., McCormak, F.X., and Kalina, M. 1997. Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A. Am. J. Physiol. 16:L1198-L1204.
67. Kalina, M., Blau, H., Riklis, S., and Kravtsov, V. 1995. Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions. Am. J. Physiol. 268:L144-L151.
68. Kuan, S.-F., Rust, K., and Crouch, E. 1992. Interactions of surfactant protein D with bacterial lipopolysaccharides. J. Clin. Invest. 90:97-106.
69. Childs, R., et al. 1992. Specificity of lung surfactant protein SP-A for both the carbohydrate and the lipid moieties of certain neutral glycolipids. J. Biol. Chem. 267:9972-9979.
70. Lesur, O., et al. 1993. Surfactant associate proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis. Lung. 171:63-74.
71. Snider, D.E., Jr. 1978. The relationship between tuberculosis and silicosis. Am. Rev. Respir. Dis. 118:445-460.